Total Payments
$148,756
2024 Payments
$78,387
Companies
32
Transactions
656
Medicare Patients
1,028
Medicare Billing
$70,406
Payment Breakdown by Category
Other$111,463 (74.9%)
Consulting$13,156 (8.8%)
Food & Beverage$12,690 (8.5%)
Travel$10,856 (7.3%)
Education$590.62 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $111,463 | 47 | 74.9% |
| Consulting Fee | $13,156 | 6 | 8.8% |
| Food and Beverage | $12,690 | 570 | 8.5% |
| Travel and Lodging | $10,856 | 26 | 7.3% |
| Education | $590.62 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $68,751 | 142 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $38,039 | 79 | $0 (2024) |
| GENZYME CORPORATION | $29,552 | 49 | $0 (2024) |
| Incyte Corporation | $5,573 | 13 | $0 (2024) |
| ABBVIE INC. | $1,470 | 86 | $0 (2024) |
| Amgen Inc. | $913.09 | 38 | $0 (2024) |
| Lilly USA, LLC | $740.82 | 37 | $0 (2024) |
| Galderma Laboratories, L.P. | $515.18 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $406.07 | 20 | $0 (2024) |
| Celgene Corporation | $395.70 | 29 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78,387 | 107 | Janssen Biotech, Inc. ($64,442) |
| 2023 | $35,861 | 213 | Regeneron Healthcare Solutions, Inc. ($15,548) |
| 2022 | $17,696 | 73 | GENZYME CORPORATION ($10,000) |
| 2021 | $5,131 | 14 | Regeneron Healthcare Solutions, Inc. ($4,124) |
| 2020 | $7,612 | 29 | Regeneron Healthcare Solutions, Inc. ($4,227) |
| 2019 | $2,376 | 123 | AbbVie, Inc. ($380.99) |
| 2018 | $1,608 | 96 | Celgene Corporation ($216.76) |
| 2017 | $84.54 | 1 | Galderma Laboratories, L.P. ($84.54) |
All Payment Transactions
656 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,128.00 | General |
| Category: Immunology | ||||||
| 11/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,865.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $634.20 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $120.73 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $57.93 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: Immunology | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $298.64 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $177.95 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $149.69 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $89.19 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,865.00 | General |
| Category: Immunology | ||||||
| 09/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,128.00 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $960.70 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $821.48 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Immunology | ||||||
| 08/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,128.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 337 | 644 | $76,540 | $22,876 |
| 2022 | 7 | 240 | 477 | $56,570 | $15,963 |
| 2021 | 7 | 264 | 478 | $59,035 | $19,583 |
| 2020 | 7 | 187 | 316 | $43,665 | $11,984 |
Total Patients
1,028
Total Services
1,915
Medicare Billing
$70,406
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 135 | $23,625 | $8,096 | 34.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 59 | 72 | $16,200 | $2,891 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 27 | $6,750 | $2,580 | 38.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 31 | 34 | $8,840 | $2,508 | 28.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 28 | 32 | $8,000 | $2,379 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $7,050 | $2,369 | 33.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 49 | 301 | $4,515 | $1,533 | 34.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,560 | $518.21 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 79 | $13,825 | $4,408 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 24 | 33 | $8,580 | $2,945 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 30 | $7,500 | $2,560 | 34.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 50 | 60 | $13,500 | $2,274 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $5,640 | $1,486 | 26.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 37 | 235 | $3,525 | $1,205 | 34.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 14 | 16 | $4,000 | $1,086 | 27.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 115 | $20,125 | $7,982 | 39.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 32 | 40 | $10,400 | $3,667 | 35.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 27 | 27 | $6,345 | $2,326 | 36.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 45 | 55 | $12,375 | $2,284 | 18.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 18 | 19 | $4,750 | $1,392 | 29.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 35 | 204 | $3,060 | $1,068 | 34.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 18 | $1,980 | $864.36 | 43.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 50 | $12,500 | $3,617 | 28.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 48 | $8,400 | $2,700 | 32.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 20 | 21 | $5,460 | $1,665 | 30.5% |
About Smita Aggarwal
Smita Aggarwal is a Dermatology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1083997142.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Smita Aggarwal has received a total of $148,756 in payments from pharmaceutical and medical device companies, with $78,387 received in 2024. These payments were reported across 656 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($111,463).
As a Medicare-enrolled provider, Aggarwal has provided services to 1,028 Medicare beneficiaries, totaling 1,915 services with total Medicare billing of $70,406. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Chicago, IL
- Active Since 09/26/2011
- Last Updated 11/09/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1083997142
Products in Payments
- TREMFYA (Drug) $68,232
- DUPIXENT (Biological) $67,039
- OPZELURA (Drug) $5,573
- Otezla (Drug) $896.82
- TALTZ (Drug) $651.63
- RINVOQ (Biological) $574.74
- Humira (Biological) $432.51
- DUPIXENT (Drug) $374.60
- STELARA (Biological) $352.54
- SKYRIZI (Biological) $314.80
- EPIDUO FORTE (Drug) $285.07
- Tremfya (Drug) $270.04
- ENSTILAR (Drug) $264.62
- ILUMYA (Biological) $229.94
- EUCRISA (Drug) $217.65
- VTAMA (Drug) $159.55
- SOOLANTRA (Drug) $158.62
- DUOBRII (Drug) $155.50
- Cimzia (Drug) $141.18
- Winlevi (Drug) $135.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chicago
Dr. Raj Chovatiya, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $2.4M
Dermatology $2.4M
Dr. Peter Lio, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Dr. Caroline Robinson, M.d, M.D
Dermatology — Payments: $266,292
Dermatology $266,292
Anthony Mancini, Md, MD
Dermatology — Payments: $206,725
Dermatology $206,725
Meyer Horn, M.d, M.D
Dermatology — Payments: $183,082
Dermatology $183,082
Dr. Faiyaaz Kalimullah, M.d, M.D
Dermatology — Payments: $164,094
Dermatology $164,094